THE FREQUENCY OF P53 IMMUNOSTAINING IN ASBESTOS-ASSOCIATED MESOTHELIOMAS AND NON-ASBESTOS-ASSOCIATED MESOTHELIOMAS

被引:14
作者
MAYALL, FG [1 ]
GODDARD, H [1 ]
GIBBS, AR [1 ]
机构
[1] UNIV WALES COLL MED,CARDIFF CF4 4XN,S GLAM,WALES
关键词
MESOTHELIOMA; ASBESTOS; P53; PROTEIN; IMMUNOHISTOCHEMISTRY; CARCINOGENESIS;
D O I
10.1111/j.1365-2559.1993.tb00140.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
It has been suggested that asbestos might have an important role in the development of p53 mutations in mesotheliomas. The objective of this study was to examine asbestos-associated mesotheliomas and non-asbestos-associated mesotheliomas to establish whether the frequency of p53 immunostaining and, by implication, p53 gene mutation is related to asbestos exposure. Immunopositivity for p53 was found in seven (44%) of the 16 mesotheliomas examined. The frequency was approximately the same in both the asbestos-associated mesotheliomas and the non-asbestos-associated mesotheliomas. It is concluded that the frequency of p 5 3 immunostaining in mesotheliomas and, by implication, the frequency of p53 gene mutation is probably not related to asbestos exposure.
引用
收藏
页码:383 / 386
页数:4
相关论文
共 32 条
[1]  
ANTMAN KH, 1985, CANCER, V54, P367
[2]   A ROLE FOR SUNLIGHT IN SKIN-CANCER - UV-INDUCED P53 MUTATIONS IN SQUAMOUS-CELL CARCINOMA [J].
BRASH, DE ;
RUDOLPH, JA ;
SIMON, JA ;
LIN, A ;
MCKENNA, GJ ;
BADEN, HP ;
HALPERIN, AJ ;
PONTEN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10124-10128
[3]   SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA [J].
BRESSAC, B ;
KEW, M ;
WANDS, J ;
OZTURK, M .
NATURE, 1991, 350 (6317) :429-431
[4]   MESOTHELIAL AND RELATED NEOPLASMS IN CHILDREN AND ADOLESCENTS - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL ANALYSIS OF 8 CASES [J].
COFFIN, CM ;
DEHNER, LP .
PEDIATRIC PATHOLOGY, 1992, 12 (03) :333-347
[5]  
COTE RJ, 1991, CANCER RES, V51, P5410
[6]   ROLE OF ASBESTOS AND OTHER FIBERS IN THE DEVELOPMENT OF DIFFUSE MALIGNANT MESOTHELIOMA [J].
GIBBS, AR .
THORAX, 1990, 45 (09) :649-654
[7]   COMPARISON OF TUMOR-MARKERS IN MALIGNANT MESOTHELIOMA AND PULMONARY ADENOCARCINOMA [J].
GIBBS, AR ;
HARACH, R ;
WAGNER, JC ;
JASANI, B .
THORAX, 1985, 40 (02) :91-95
[8]   FAMILIAL MESOTHELIOMA - A REPORT OF 2 FAMILIES [J].
HAMMAR, SP ;
BOCKUS, D ;
REMINGTON, F ;
FREIDMAN, S ;
LAZERTE, G .
HUMAN PATHOLOGY, 1989, 20 (02) :107-112
[9]   MUTANT P53 - THE COMMONEST GENETIC ABNORMALITY IN HUMAN CANCER [J].
HARRIS, AL .
JOURNAL OF PATHOLOGY, 1990, 162 (01) :5-6
[10]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53